{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:08:24Z","timestamp":1785434904979,"version":"3.56.0"},"reference-count":72,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Florida"},{"id":[{"id":"https:\/\/ror.org\/02y3ad647","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Chronic pain affects hundreds of millions of people and remains poorly managed, as the most effective drugs, including opioids, carry side effects that limit long-term use. Because inflammation drives both the initiation and maintenance of chronic pain, anti-inflammatory mechanisms are an attractive analgesic target. We investigated human alpha-1 antitrypsin (hAAT), a serine proteinase inhibitor with potent anti-inflammatory activity and established protection across disease models, as a candidate analgesic, using Aralast NP\u00ae, a clinical-grade, already-approved formulation that makes findings directly translatable. Using calcium imaging and patch-clamp electrophysiology in mouse dorsal root ganglion (DRG) neurons, we found that hAAT reduced activation of low-voltage-activated Ca2+ channels and dampened intrinsic excitability. Veratridine-evoked Ca2+ responses, a sodium-channel-dependent readout of nociceptor activity, were suppressed by hAAT to a degree comparable to the selective sodium channel inhibitors ProTx-II (NaV1.7) and VX-548 (NaV1.8), driven by loss of the nociceptor-associated response profiles. In vivo, hAAT decreased pain sensitivity and pain-associated behaviors in both inflammatory and neuropathic models. Together, these findings reveal a mechanism by which hAAT suppresses nociceptor activity and position Aralast NP\u00ae as a safe, effective candidate for treating chronic pain.<\/jats:p>","DOI":"10.3390\/biom16081074","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:11:42Z","timestamp":1784787102000},"page":"1074","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human \u03b11-Antitrypsin Inhibits Nociceptor Excitability and Relieves Inflammatory and Neuropathic Pain"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7706-0573","authenticated-orcid":false,"given":"Alaina L.","family":"Waters","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Therapeutics and Center for Advanced Pain Therapeutics and Research, College of Medicine, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6207-8370","authenticated-orcid":false,"given":"Santiago","family":"Loya-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics and Center for Advanced Pain Therapeutics and Research, College of Medicine, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9940-363X","authenticated-orcid":false,"given":"Erick J.","family":"Rodriguez-Palma","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics and Center for Advanced Pain Therapeutics and Research, College of Medicine, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4995-1410","authenticated-orcid":false,"given":"Shainnel O.","family":"Eans","sequence":"additional","affiliation":[{"name":"Department of Cellular and Systems Pharmacology, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7852-0589","authenticated-orcid":false,"given":"Ryosuke","family":"Shinouchi","sequence":"additional","affiliation":[{"name":"Department of Cellular and Systems Pharmacology, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Stokes","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9851-9342","authenticated-orcid":false,"given":"Jay P.","family":"McLaughlin","sequence":"additional","affiliation":[{"name":"Department of Cellular and Systems Pharmacology, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6523-165X","authenticated-orcid":false,"given":"Sihong","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9066-2969","authenticated-orcid":false,"given":"Rajesh","family":"Khanna","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics and Center for Advanced Pain Therapeutics and Research, College of Medicine, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: The IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jpain.2012.03.009","article-title":"The economic costs of pain in the United States","volume":"13","author":"Gaskin","year":"2012","journal-title":"J. Pain"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"21501319241233463","DOI":"10.1177\/21501319241233463","article-title":"Association of Risk Factors and Comorbidities with Chronic Pain in the Elderly Population","volume":"15","author":"Mookerjee","year":"2024","journal-title":"J. Prim. Care Community Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"104620","DOI":"10.1016\/j.jpain.2024.104620","article-title":"Examining the Relationship Between Chronic Pain and Mortality in U.S. Adults","volume":"25","author":"Ray","year":"2024","journal-title":"J. Pain"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/j.pain.0000000000002688","article-title":"Combination pharmacotherapy for the treatment of neuropathic pain in adults: Systematic review and meta-analysis","volume":"164","author":"Balanaser","year":"2023","journal-title":"Pain"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17448069231178176","DOI":"10.1177\/17448069231178176","article-title":"Inflammation in pathogenesis of chronic pain: Foe and friend","volume":"19","author":"Fang","year":"2023","journal-title":"Mol. Pain"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/cns.12486","article-title":"Preclinical Assessment of Inflammatory Pain","volume":"22","author":"Muley","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd4334","article-title":"Emerging targets in neuroinflammation-driven chronic pain","volume":"13","author":"Ji","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1097\/j.pain.0000000000001524","article-title":"Targeting the CaV\u03b1-CaV\u03b2 interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy","volume":"160","author":"Khanna","year":"2019","journal-title":"Pain"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"109057","DOI":"10.1016\/j.neuropharm.2022.109057","article-title":"The small molecule compound C65780 alleviates pain by stabilizing voltage-gated sodium channels in the inactivated and slowly-recovering state","volume":"212","author":"Kong","year":"2022","journal-title":"Neuropharmacology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/hum.2006.17.625","article-title":"Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice","volume":"17","author":"Lu","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jgm.1409","article-title":"Combination of alpha-1 antitrypsin and doxycycline suppresses collagen-induced arthritis","volume":"12","author":"Grimstein","year":"2010","journal-title":"J. Gene Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.12.029","article-title":"Alpha 1-antitrypsin therapy mitigated ischemic stroke damage in rats","volume":"23","author":"Moldthan","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Elshikha, A.S., Lu, Y., Chen, M.J., Akbar, M., Zeumer, L., Ritter, A., Elghamry, H., Mahdi, M.A., Morel, L., and Song, S. (2016). Alpha 1 Antitrypsin Inhibits Dendritic Cell Activation and Attenuates Nephritis in a Mouse Model of Lupus. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0156583"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S280","DOI":"10.1513\/AnnalsATS.201507-468KV","article-title":"Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments","volume":"13","author":"Janciauskiene","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kilkenny, C., Browne, W.J., Cuthill, I.C., Emerson, M., and Altman, D.G. (2010). Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biol., 8.","DOI":"10.1371\/journal.pbio.1000412"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/bph.15974","article-title":"The natural product argentatin C attenuates postoperative pain via inhibition of voltage-gated sodium and T-type voltage-gated calcium channels","volume":"180","author":"Duran","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"eabh1314","DOI":"10.1126\/scitranslmed.abh1314","article-title":"Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents","volume":"13","author":"Cai","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1124\/mol.111.073205","article-title":"TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent","volume":"80","author":"Choe","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"F350","DOI":"10.1152\/ajprenal.00681.2010","article-title":"Norepinephrine reduces \u03c9-conotoxin-sensitive Ca2+ currents in renal afferent neurons in rats","volume":"302","author":"Ditting","year":"2012","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"16698","DOI":"10.1021\/jacs.4c04025","article-title":"C-H Functionalization-Enabled 11-Step Semisynthesis of (-)-Veragranine A and Characterization of Synthetic Analogs in Osteoarthritis-related Pain Treatment","volume":"146","author":"Ma","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"45221","DOI":"10.1038\/srep45221","article-title":"Veratridine produces distinct calcium response profiles in mouse Dorsal Root Ganglia neurons","volume":"7","author":"Mohammed","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Mottinelli, M., Journigan, V.B., Obeng, S., Pallares, V.L.C., M\u00e8sangeau, C., Kapanda, C.N., Cutler, S.J., Lambert, J.A., Eans, S.O., and Ganno, M.L. (2025). Dual Opioid-Neuropeptide FF Small Molecule Ligands Demonstrate Analgesia with Reduced Tolerance Liabilities. Molecules, 30.","DOI":"10.3390\/molecules30132851"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1163\/156856004773121374","article-title":"Effect of selective inhibition of cyclooxygenase-2 on lipopolysaccharide-induced hyperalgesia","volume":"12","author":"Satyanarayana","year":"2004","journal-title":"Inflammopharmacology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.3892\/mmr.2016.5027","article-title":"Resveratrol attenuates inflammatory hyperalgesia by inhibiting glial activation in mice spinal cords","volume":"13","author":"Wang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Cirino, T.J., Eans, S.O., Medina, J.M., Wilson, L.L., Mottinelli, M., Intagliata, S., McCurdy, C.R., and McLaughlin, J.P. (2019). Characterization of Sigma 1 Receptor Antagonist CM-304 and Its Analog, AZ-66: Novel Therapeutics Against Allodynia and Induced Pain. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00678"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(00)00276-1","article-title":"Spared nerve injury: An animal model of persistent peripheral neuropathic pain","volume":"87","author":"Decosterd","year":"2000","journal-title":"Pain"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"100174","DOI":"10.1016\/j.ynpai.2024.100174","article-title":"Targeting Na(v)1.7 and Na(v)1.8 with a PIKfyve inhibitor to reverse inflammatory and neuropathic pain","volume":"17","author":"Min","year":"2025","journal-title":"Neurobiol. Pain"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00424-010-0784-6","article-title":"Understanding inflammatory pain: Ion channels contributing to acute and chronic nociception","volume":"459","author":"Linley","year":"2010","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tins.2022.12.007","article-title":"Persistent nociceptor hyperactivity as a painful evolutionary adaptation","volume":"46","author":"Walters","year":"2023","journal-title":"Trends Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1124\/mol.108.047670","article-title":"ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors","volume":"74","author":"Schmalhofer","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa2209870","article-title":"Selective Inhibition of Na(V)1.8 with VX-548 for Acute Pain","volume":"389","author":"Jones","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1085\/jgp.91.3.421","article-title":"Veratridine modifies open sodium channels","volume":"91","author":"Barnes","year":"1988","journal-title":"J. Gen. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1128\/iai.62.11.4975-4980.1994","article-title":"Evidence for lipopolysaccharide as the predominant proinflammatory mediator in supernatants of antibiotic-treated bacteria","volume":"62","author":"Leeson","year":"1994","journal-title":"Infect. Immun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: An evaluation of the method","volume":"51","author":"Berge","year":"1992","journal-title":"Pain"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-0270(85)90116-5","article-title":"Formalin test in mice, a useful technique for evaluating mild analgesics","volume":"14","author":"Hunskaar","year":"1985","journal-title":"J. Neurosci. Methods"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kelly-Robinson, G.A., Reihill, J.A., Lundy, F.T., McGarvey, L.P., Lockhart, J.C., Litherland, G.J., Thornbury, K.D., and Martin, S.L. (2021). The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126351"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/gb-2006-7-5-216","article-title":"An overview of the serpin superfamily","volume":"7","author":"Law","year":"2006","journal-title":"Genome Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1073\/pnas.1309648110","article-title":"Anti-inflammatory and immunomodulatory properties of \u03b11-antitrypsin without inhibition of elastase","volume":"110","author":"Jonigk","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S305","DOI":"10.1513\/AnnalsATS.201510-671KV","article-title":"Alpha-1 Antitrypsin Deficiency: Beyond the Protease\/Antiprotease Paradigm","volume":"13","author":"Cosio","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Lior, Y., Zaretsky, M., Ochayon, D.E., Lotysh, D., Baranovski, B.M., Schuster, R., Guttman, O., Aharoni, A., and Lewis, E.C. (2018). Point Mutation of a Non-Elastase-Binding Site in Human \u03b11-Antitrypsin Alters Its Anti-Inflammatory Properties. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00759"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, M.E., Murray, G., Gogoi, D., Yusuf, A., McCarthy, C., Wormald, M.R., Casey, M., Gabillard-Lefort, C., McElvaney, N.G., and Reeves, E.P. (2022). A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052441"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1189\/jlb.0208145","article-title":"Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood","volume":"85","author":"Pott","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_46","first-page":"289","article-title":"Alpha-1 Antitrypsin Therapy for Autoimmune Disorders","volume":"5","author":"Song","year":"2018","journal-title":"Chronic Obstr. Pulm. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Elshikha, A.S., Abboud, G., Avdiaj, R., Morel, L., and Song, S. (2025). The Inhibitory Effects of Alpha 1 Antitrypsin on Endosomal TLR Signaling Pathways. Biomolecules, 15.","DOI":"10.3390\/biom15010043"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1165\/rcmb.2011-0231OC","article-title":"\u03b11-antitrypsin production by proinflammatory and antiinflammatory macrophages and dendritic cells","volume":"46","author":"Savage","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/ajt.16342","article-title":"Alpha-1 antitrypsin suppresses macrophage activation and promotes islet graft survival after intrahepatic islet transplantation","volume":"21","author":"Gou","year":"2021","journal-title":"Am. J. Transplant."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.emboj.7600515","article-title":"Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception","volume":"24","author":"Bourinet","year":"2005","journal-title":"EMBO J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1601-183X.2006.00268.x","article-title":"Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels","volume":"6","author":"Choi","year":"2007","journal-title":"Genes Brain Behav."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Joksimovic, S.L., Joksimovic, S.M., Tesic, V., Garc\u00eda-Caballero, A., Feseha, S., Zamponi, G.W., Jevtovic-Todorovic, V., and Todorovic, S.M. (2018). Selective inhibition of Ca(V)3.2 channels reverses hyperexcitability of peripheral nociceptors and alleviates postsurgical pain. Sci. Signal., 11.","DOI":"10.1126\/scisignal.aao4425"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.trsl.2021.01.002","article-title":"Targeting T-type\/CaV3.2 channels for chronic pain","volume":"234","author":"Cai","year":"2021","journal-title":"Transl. Res."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Chen, W., Chi, Y.N., Kang, X.J., Liu, Q.Y., Zhang, H.L., Li, Z.H., Zhao, Z.F., Yang, Y., Su, L., and Cai, J. (2018). Accumulation of Ca(v)3.2 T-type Calcium Channels in the Uninjured Sural Nerve Contributes to Neuropathic Pain in Rats with Spared Nerve Injury. Front. Mol. Neurosci., 11.","DOI":"10.3389\/fnmol.2018.00024"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nn.3602","article-title":"Regulating excitability of peripheral afferents: Emerging ion channel targets","volume":"17","author":"Waxman","year":"2014","journal-title":"Nat. Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/j.pain.0000000000000453","article-title":"Upregulation of the sodium channel NaV\u03b24 subunit and its contributions to mechanical hypersensitivity and neuronal hyperexcitability in a rat model of radicular pain induced by local dorsal root ganglion inflammation","volume":"157","author":"Xie","year":"2016","journal-title":"Pain"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Rangel-Galv\u00e1n, M., Rangel-Galv\u00e1n, V., and Rangel-Huerta, A. (2023). T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1212800"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e22093","DOI":"10.1096\/fj.202101031RR","article-title":"\u03b11-Antitrypsin derived SP16 peptide demonstrates efficacy in rodent models of acute and neuropathic pain","volume":"36","author":"Wang","year":"2022","journal-title":"FASEB J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e21472","DOI":"10.1096\/fj.202001801R","article-title":"Alpha-1-antitrypsin reduces inflammation and exerts chondroprotection in arthritis","volume":"35","author":"Kaneva","year":"2021","journal-title":"FASEB J."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Calil, I.L., Zarpelon, A.C., Guerrero, A.T., Alves-Filho, J.C., Ferreira, S.H., Cunha, F.Q., Cunha, T.M., and Verri, W.A. (2014). Lipopolysaccharide induces inflammatory hyperalgesia triggering a TLR4\/MyD88-dependent cytokine cascade in the mice paw. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090013"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ilar.40.3.111","article-title":"Inflammatory Models of Pain and Hyperalgesia","volume":"40","author":"Ren","year":"1999","journal-title":"ILAR J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood-2018-99-111872","article-title":"Targeting Elastase with Alpha1 Anti-Trypsin Reduces Hyperalgesia in Mice with Sickle Cell Disease","volume":"132","author":"Nguyen","year":"2018","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Zhukovsky, N., Silvano, M., Filloux, T., Gonzalez, S., and Krause, K.H. (2022). Alpha-1 Antitrypsin Reduces Disease Progression in a Mouse Model of Charcot-Marie-Tooth Type 1A: A Role for Decreased Inflammation and ADAM-17 Inhibition. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137405"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nn.4053","article-title":"Different immune cells mediate mechanical pain hypersensitivity in male and female mice","volume":"18","author":"Sorge","year":"2015","journal-title":"Nat. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Kryvalap, Y., and Czyzyk, J. (2022). The Role of Proteases and Serpin Protease Inhibitors in \u03b2-Cell Biology and Diabetes. Biomolecules, 12.","DOI":"10.3390\/biom12010067"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.bbamcr.2018.07.004","article-title":"Differential regulation of ion channels function by proteolysis","volume":"1865","author":"Wang","year":"2018","journal-title":"Biochim. Biophys. Acta BBA Mol. Cell Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm.3852","article-title":"The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase","volume":"21","author":"Strochlic","year":"2015","journal-title":"Nat. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1006\/geno.2002.6864","article-title":"The murine alpha(1)-proteinase inhibitor gene family: Polymorphism, chromosomal location, and structure","volume":"80","author":"Barbour","year":"2002","journal-title":"Genomics"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/oxfordjournals.molbev.a004130","article-title":"Functional diversification during evolution of the murine alpha(1)-proteinase inhibitor family: Role of the hypervariable reactive center loop","volume":"19","author":"Barbour","year":"2002","journal-title":"Mol. Biol. Evol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1073\/pnas.1713689115","article-title":"Editing out five","volume":"115","author":"Borel","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12974-017-0944-0","article-title":"Prophylactic inhibition of neutrophil elastase prevents the development of chronic neuropathic pain in osteoarthritic mice","volume":"14","author":"Muley","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"ref_72","first-page":"282","article-title":"Recombinant Alpha-1 Antitrypsin-Fc Fusion Protein INBRX-101 in Adults with Alpha-1 Antitrypsin Deficiency: A Phase 1 Study","volume":"11","author":"Brantly","year":"2024","journal-title":"Chronic Obstr. Pulm. Dis."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/8\/1074\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:15:17Z","timestamp":1784952917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/8\/1074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":72,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["biom16081074"],"URL":"https:\/\/doi.org\/10.3390\/biom16081074","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}